About: Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal ("GI") tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.60 (-0.22%)
ONCY NASDAQ Oncolytics Biotech Inc
Oncolytics Biotech Inc share price
ONCY price activity
Último preço
$ 0,600
Variação (24h)
-0,00 USD (-0,22%)
Volume
596.99K
Volume (média 4 sem.)
-
Abertura
$ 0,59
Variação do dia
$ 0,58 - $ 0,61
Fechamento anterior
$ 0,60
Último negócio
07 Oct, 6:59 pm GMT+0
Atrasado
07 Oct, 6:59 pm GMT+0
ONCY price performance
Atrasado
07 Oct, 6:59 pm GMT+0
quote.marketSignals